Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,36119,380 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Supernumerary Centrosomes and Cell Proliferation
NATIONAL CANCER INSTITUTE California Institute of Technology United States 2021 – 2026

PROJECT SUMMARY The centriole is a conserved organelle of metazoans that is found at the core of microtubule organizing centers, centrosomes, and at the base of cilia and flagellae...

$4.83M
USD
Completed TRAINING, INDIVIDUAL
The Mitochondrial Calcium Uniporter in Pancreatic Cancer Development, Metastasis, and Treatment
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

Summary: Pancreatic adenocarcinoma (PDAC) is a particularly lethal form of cancer which kills over 40,000 Americans every year. PDAC is most often diagnosed when disease is advance...

$717.9K
USD
Completed NON-SBIR/STTR RPGS
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

PROJECT SUMMARY ABSTRACT High-risk resectable melanoma patients (MPs) with clinically detectable stage III with or without in-transit metastases have high-risk relapse1. Neoadjuvan...

$5.34M
USD
Completed NON-SBIR/STTR RPGS
Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

Project Summary Advances in human genetics have identified +400 genes that when amplified or mutated promote tumorigenesis. While there has been huge success in developing drugs fo...

$1.92M
USD
Completed TRAINING, INDIVIDUAL
Engineering Hybrid SynNotch CAR Receptors to Enhance Cell Therapies for Cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2023

Chimeric Antigen T Cell (CAR-T) therapies, which redirect a patient’s own T cells towards their cancer, are very promising therapies for difficult to treat and refractory cancers....

$248.2K
USD
Completed NON-SBIR/STTR RPGS
Lactate production by tumor associated macrophages promotes tumorigenesis
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2026

ABSTRACT Tumor-associated macrophages (TAMs) are the most prevalent immune cell in the tumor microenvironment. TAMs adopt an M2-like phenotype that supports angiogenesis, attenuate...

$5.53M
USD
Completed NON-SBIR/STTR RPGS
Reposition and Optimization of Deferiprone for Breast Cancer Therapy
NATIONAL CANCER INSTITUTE Georgia Institute of Technology United States 2021 – 2026

Project Summary/Abstract: In 2020 there will be ~ 276,480 estimated new cases of invasive breast cancer (BCa) among women in the US, causing an estimated ~ 42,170 deaths. Two commo...

$5.32M
USD
Completed NON-SBIR/STTR RPGS
Role of Sirt2 in T Cell Metabolism
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2023

PROJECT SUMMARY Metabolism is a key driver of T cell functions, and the switch from oxidative-phosphorylation to aerobic glycolysis is a hallmark of T cell activation. Unfortunatel...

$1.92M
USD
Completed NON-SBIR/STTR RPGS
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

Clinical radiation therapy is a noninvasive means to mitigate cancer progression, which is prescribed for more than 50% of prostate cancer patients. Development of radiation techno...

$6.52M
USD
Completed NON-SBIR/STTR RPGS
Technology Facilitated Behavioral Intervention for Depression among Diverse Patients in Ambulatory Oncology
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

AbstractDepressionis one of the most common psychological comorbidities experienced throughout the cancercontinuum. Elevated depressive symptoms in oncology patients is a major con...

$6.2M
USD
Completed TRAINING, INDIVIDUAL
Identifying the Role of Tumor Cell Intrinsic DNMT1 in Anti-Tumor Immunity in Pancreatic Ductal Adenocarcinoma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary Pancreatic ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer-related death in the United States. The five-year survival rate of less than...

$353.9K
USD
Completed NON-SBIR/STTR RPGS
Image-based models of tumor-immune dynamics in glioblastoma
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2021 – 2026

ABSTRACT The use of immunotherapy to treat cancer continues to generate hope and excitement among those involved in cancer care and research. However, our inability to explain why...

$105.7K
USD
Completed NON-SBIR/STTR RPGS
Diversity Supplement Ifediora: Image-based models of tumor-immune dynamics in glioblastoma
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2021 – 2026

Abstract Glioblastoma Multiforme (GBM) is the most common of all gliomas with a median survival 14-18 months, despite aggressive treatment regimens. However, glioma is a disease th...

$813K
USD
Completed NON-SBIR/STTR RPGS
Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2021 – 2026

Project Summary The overarching goal of this project is to develop a tumor organoid-based drug screening platform that quantifies the differential drug responsiveness of tumor clon...

$4.94M
USD
Completed NON-SBIR/STTR RPGS
Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

Abstract: The Hippo pathway is an evolutionarily conserved signaling cascade regulating numerous biological processes, including cell growth and fate decision, organ size control,...

$2.49M
USD
Completed OTHER RESEARCH-RELATED
Reprogramming the chimeric antigen receptor T cell epigenome to augment anti-tumor activity
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The candidate for this NCI Career Development Award is Max Jan, MD, PhD, who has completed clinical training in molecular genetic pathology and is a curren...

$1.89M
USD
Completed NON SBIR/STTR CONTRACTS
BIOSPECIMEN PROCESSING CENTER (BPC) - EARLY ONSET MALIGNANCIES INITIATIVE
NATIONAL CANCER INSTITUTE Research Inst Nationwide Children'S Hosp United States 2021 – 2024

This Task Order provides support to the Early Onset Malignancies Initiative (EOMI).The EOMI is a collaborative initiative between CCG and the Division of Cancer Prevention’s NCI Co...

$1.56M
USD
Active NON-SBIR/STTR RPGS
Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2027

PROJECT SUMMARY Chromatin-based DNA damage response (DDR) pathway is fundamental for protecting cells from genome instability, which is a hallmark of cancer. The DDR pathway is tig...

$2.4M
USD
Active NON-SBIR/STTR RPGS
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY Most children treated for cancer in the US will achieve long-term survival, and survivorship presents unique challenges for this growing population. Pediatric brain...

$379.8K
USD
Completed TRAINING, INDIVIDUAL
Development of a combined ARFI/SWEI ultrasound elasticity imaging system for targeted prostate biopsy guidance
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2023

ABSTRACT Prostate cancer is the most common cancer among men in the United States, and early detection is crucial for effective treatment or management. Following an initial screen...

$160.1K
USD